Cushing’s disease is caused by a small, noncancerous tumor on the pituitary gland that pumps out too much of a hormone called ACTH. This hormone travels to the adrenal glands (which sit on top of your kidneys) and forces them to produce excess cortisol, flooding the body with levels far beyond what it needs. The condition is rare, affecting roughly 1.6 people per million each year, with an average age at diagnosis of 43.
The Pituitary Tumor at the Core
Nearly all cases of Cushing’s disease trace back to a single source: a pituitary adenoma. The pituitary is a pea-sized gland at the base of the brain that acts as a master controller for hormone production throughout the body. In healthy people, the brain’s hypothalamus sends a signal (a hormone called CRH) to the pituitary, which responds by releasing ACTH. ACTH then tells the adrenal glands to make cortisol. When cortisol levels rise high enough, the system shuts itself off through a feedback loop.
In Cushing’s disease, a tumor on the pituitary ignores that feedback signal. It keeps secreting ACTH regardless of how much cortisol is already circulating. The adrenal glands have no choice but to keep producing cortisol in response. The result is a body chronically soaked in cortisol, which disrupts metabolism, immunity, bone density, mood, and cardiovascular health.
Most of these tumors are microadenomas, meaning they measure less than 10 millimeters across. Some are macroadenomas (10 mm or larger), and in rare cases giant adenomas exceed 40 mm. Because most are so small, they can be difficult to spot on imaging, which is one reason the disease often goes undiagnosed for years.
Cushing’s Disease vs. Cushing’s Syndrome
These two terms get confused constantly, and the distinction matters. Cushing’s syndrome is the broader category: any condition where the body has too much cortisol over a long period. The most common cause is actually taking prescription corticosteroid medications for conditions like asthma, arthritis, or autoimmune disease. Other causes include tumors on the adrenal glands themselves or ACTH-producing tumors elsewhere in the body (like the lungs).
Cushing’s disease refers specifically to the pituitary tumor cause. It accounts for about 8 out of 10 cases of Cushing’s syndrome that aren’t caused by medications. So when someone says “Cushing’s disease,” they’re pointing to the pituitary as the problem.
Genetic Mutations Behind the Tumor
Researchers have made significant progress identifying what goes wrong at the genetic level inside these pituitary tumors. The most common finding involves mutations in a gene called USP8. A landmark study published in Cell Research found USP8 mutations in 62% of ACTH-secreting pituitary tumors examined. These mutations were gain-of-function, meaning they made the gene overactive in ways that drive tumor growth and hormone overproduction. Importantly, none of these mutations appeared in other types of pituitary tumors, suggesting they play a specific role in Cushing’s disease.
For the remaining tumors without USP8 mutations, the genetic picture is murkier. Isolated cases have involved mutations in genes related to the glucocorticoid receptor (NR3C1), tumor suppressor genes like p53, and a handful of others. But no single mutation has emerged as a dominant driver in the way USP8 has for the majority of cases. Most Cushing’s disease occurs sporadically, without a clear inherited pattern, though rare familial syndromes can include pituitary tumors as one feature.
What Excess Cortisol Does to the Body
Cortisol is essential in small amounts. It regulates blood sugar, controls inflammation, and helps you respond to stress. But when levels stay elevated for months or years, the damage is widespread. The most recognizable signs include weight gain concentrated in the face, upper back, and abdomen, while the arms and legs may actually thin out. Skin becomes fragile, bruises easily, and develops wide purple or red stretch marks. Many people notice muscle weakness, fatigue, and mood changes ranging from anxiety to depression.
The metabolic consequences are serious. Studies tracking patients with Cushing’s disease show that roughly 64 to 75% develop high blood pressure, and around 78 to 79% develop abnormal blood sugar levels. Left completely untreated, Cushing’s disease carries a 5-year survival rate of just 50%, largely because of cardiovascular complications, infections, and blood clots. Even after successful treatment, some of these metabolic problems can linger. Two years after surgical remission, about 44% of patients still had hypertension and 39% still had elevated blood sugar, though both figures represent meaningful improvement from baseline.
How the Cause Is Pinpointed
Diagnosing Cushing’s disease involves two separate challenges: first confirming that cortisol is too high, then proving the pituitary is the source.
The initial screening typically involves measuring cortisol at times when it should be at its lowest. Your body normally drops cortisol production late at night, so a saliva sample collected before bed can reveal whether levels remain inappropriately elevated. A late-night salivary cortisol value above 3.3 nmol/L has a sensitivity of about 95% and specificity of 97% for identifying the condition. Doctors may also collect urine over 24 hours to measure total cortisol output, or use a suppression test that gives you a synthetic steroid to see whether your body’s cortisol production responds normally to feedback.
Once excess cortisol is confirmed, blood tests measuring ACTH help narrow the cause. High cortisol paired with high ACTH points toward a pituitary or other ACTH-producing tumor, rather than an adrenal problem (which would suppress ACTH). An MRI of the pituitary can often reveal the adenoma, but because many tumors are tiny, imaging misses them in a significant number of cases.
When the MRI is inconclusive, doctors may recommend a procedure called inferior petrosal sinus sampling. Thin catheters are threaded through veins to collect blood samples from the veins draining directly from the pituitary, then compared with blood from a peripheral vein. If ACTH concentrations are much higher near the pituitary, the tumor is confirmed as the source. This test is highly accurate, with sensitivity reaching 96 to 98% and near-perfect specificity.
Treatment and Long-Term Outlook
The primary treatment is surgery to remove the pituitary tumor, performed through the nose and sinuses in a procedure called transsphenoidal surgery. When the tumor is clearly identified and fully removed, patients can enter remission, with cortisol levels dropping to normal or even temporarily below normal as the body readjusts.
Long-term outcomes, however, require realistic expectations. One study following 45 patients who achieved initial remission after surgery found that 10 of them (22%) relapsed over an average follow-up of nearly 10 years. The average time to relapse was 5.3 years, which is why ongoing monitoring matters long after surgery feels like a success. The overall remission rate in that cohort, including patients who didn’t achieve initial remission, was 56% at the 9.6-year mark.
For patients who relapse or aren’t candidates for surgery, options include repeat surgery, radiation therapy aimed at the pituitary, medications that reduce cortisol production or block its effects, and in some cases removal of the adrenal glands as a last resort. Each of these carries its own tradeoffs in terms of effectiveness and side effects, and the right path depends on the individual case.
Even after cortisol levels normalize, recovery is gradual. The body needs time to rebuild bone density, restore muscle strength, and recalibrate metabolism. Many patients describe a period of months to years before they feel like themselves again, and some metabolic effects like high blood pressure may persist long after the cortisol problem is resolved.